Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis
NCT01206569
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
Interventions
DRUG:
Long-acting tacrolimus (Advagraf, Astellas Pharma)
Sponsor
Chinese University of Hong Kong